Vaccines

The Coalition for Pandemic Preparedness played a key part in speeding development of COVID-19 vaccines. It now needs support over the next five years to end the pandemic and be ready for future infectious disease outbreaks

Head of EU pharma trade body says waiver would ‘open the door to counterfeit vaccines’ and kill incentives to tackle dangerous virus variants. ‘Who will make the vaccine next time?’ one pharma chief asks

As the problem of COVID-19 vaccines supplies so potently illustrates, it is time to rethink the EU’s pandemic preparedness strategy. More support is needed for late stage clinical development and large scale manufacturing

US biotech Moderna says its vaccine can be repurposed ‘in weeks’ to deal with coronavirus mutations